48-week efficacy and safety of transitioning virologically stable HIV-1 patients from nevirapine IR 200 mg BID to nevirapine XR 400 mg QD (TRANxITION)

Arastéh, K; Ward, A; Plettenberg, A; Livrozet, JM; Cordes, C; Winston, A; Wang, E; Quinson, A

doi:10.1186/1758-2652-13-S4-P45

Journal of the International AIDS Society

Article metrics
Last updated: Thu, 25 Apr 2024 16:44:01 Z

48-week efficacy and safety of transitioning virologically stable HIV-1 patients from nevirapine IR 200 mg BID to nevirapine XR 400 mg QD (TRANxITION)

Access & Citations

2152

Article Accesses
0

Web of Science
5

CrossRef

Citation counts are provided from Web of Science and CrossRef. The counts may vary by service, and are reliant on the availability of their data. Counts will update daily once available.